Additional file 3: of Decision aids for second-line palliative chemotherapy: a randomised phase II multicentre trial

Additional file 1: of Recognizing difficult trade-offs: values and treatment preferences for end-of-life care in a multi-site survey of adult patients in family practices

Michelle Howard (3274704)
Nick Bansback (185069)
Amy Tan (4667998)
Doug Klein (4667992)
Carrie Bernard (4668001)
Doris Barwich (4667995)
Peter Dodek (54684)
Aman Nijjar (4667989)
Daren Heyland (614600)

December 2017

Questionnaire asking patients about engagement in advance care planning. (DOCX 37Â kb

Additional file 2: of How do professionals assess the quality of life of children with advanced cancer receiving palliative care, and what are their recommendations for improvement?

Josianne Avoine-Blondin (5185145)
Véronique Parent (5185142)
Léonor Fasse (4596292)
Clémentine Lopez (5185151)
Nago Humbert (5185148)
Michel Duval (447435)
Serge Sultan (201149)

May 2018

Signs associated with the dimensions of QoL from the perspective of professionals in hematology-onco...

Additional file 2: of Characteristics and impact of the most-cited palliative oncology studies from 1995 to 2016

Corbin Eule (6113687)
Nizar Bhulani (3436592)
Elizabeth Paulk (6113690)
Ramona Rhodes (6113693)
Muhammad Beg (6113696)

January 2019

Table S2. Top 100 most-cited palliative oncology studies in 2006-2016. (XLSX 23 kb

Additional file 1: of A randomized controlled trial of a skills training for oncologists and a communication aid for patients to stimulate shared decision making about palliative systemic treatment (CHOICE): study protocol

I. Henselmans (4744968)
E. Smets (4744965)
J. de Haes (4744974)
M. Dijkgraaf (4744971)
F. de Vos (4744962)
H. van Laarhoven (4744977)

January 2018

Instruments main outcome measures (OPTION12 and 4SDM). Instruments used to assess the main outcome (...

Additional file 1: of Access to clinical trials among oncology patients: results of a cross sectional survey

Mariko Carey (671862)
Allison Boyes (2563240)
Rochelle Smits (4444474)
Jamie Bryant (671861)
Amy Waller (2563246)
Ian Olver (3903175)

September 2017

Clinical Trials Questionnaire. Participation in Clinical Trials: Questionnaire items assessing parti...

Additional file 1: of Patientsâ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey

Sing Moorcraft (3426695)
Cheryl Marriott (3426683)
Clare Peckitt (3426692)
David Cunningham (294575)
Ian Chau (3426698)
Naureen Starling (3426686)
David Watkins (384424)
Sheela Rao (3426689)

January 2016

Questionnaire A. Description: questionnaire given to patients who consented to a clinical trial. (DO...

Additional file 2: of Patientsâ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey

Sing Moorcraft (3426695)
Cheryl Marriott (3426683)
Clare Peckitt (3426692)
David Cunningham (294575)
Ian Chau (3426698)
Naureen Starling (3426686)
David Watkins (384424)
Sheela Rao (3426689)

January 2016

Questionnaire B. Description: questionnaire given to patients who declined a clinical trial. (DOC 15...

Additional file 1: of Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy

Loisa Drozdoff (5784020)
Evelyn Klein (3166416)
Marion Kiechle (268312)
Daniela Paepke (5784023)

November 2018

Questionnaire. This additional file contains the delivered survey for the patients of our chemothera...

Additional file 3: of From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards

Júlia Perera-Bel (4968799)
Barbara Hutter (420459)
Christoph Heining (4968805)
Annalen Bleckmann (318840)
Martina Fröhlich (2186257)
Stefan Fröhling (4968802)
Hanno Glimm (200902)
Benedikt Brors (14082)
Tim Beißbarth (31587)

March 2018

Percentage of patients of the top ten biomarkers at each level of evidence in each tumor type. Level...

Additional file 1: of A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer

Kazuhisa Yamaguchi (3473369)
Hiroya Taniguchi (3473354)
Azusa Komori (3473363)
Yukiya Narita (3473339)
Sohei Nitta (3473345)
Motoo Nomura (3473360)
Shigenori Kadowaki (3473348)
Daisuke Takahari (3473351)
Takashi Ura (3473366)
Masashi Andoh (3473357)
Kei Muro (3473336)
Keita Mori (428401)
Yoshinori Igarashi (3473342)

August 2015

Summary of chemotherapies for metastatic colorectal cancer in the various setting. (PDF 133Â kb

Additional file 1: of Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)

W. Koemans (6670517)
R. Kaaij (6670523)
H. Boot (3665377)
T. Buffart (6670529)
A. Veenhof (6670532)
K. Hartemink (6670535)
C. Grootscholten (6670538)
P. Snaebjornsson (6670541)
V. Retel (6670544)
H. Tinteren (6670547)
S. Vanhoutvin (6670550)
V. Noort (6670553)
A. Houwink (6670556)
C. Hahn (3977039)
A. Huitema (6670559)
M. Lahaye (1559098)
M. Los (4258465)
P. Barselaar (6670562)
O. Imhof (6670565)
A. Aalbers (6670568)
G. Dam (6088175)
B. Etten (6670571)
B. Wijnhoven (6670574)
M. Luyer (6670577)
D. Boerma (6670580)
J. Sandick (6670583)

May 2019

Inclusion and exclusion criteria of the PERISCOPE II trial. List of all in and exclusion criteria. (...

Additional file 1: of The changing landscape of phase II/III metastatic sarcoma clinical trialsâanalysis of ClinicalTrials.gov

Y Que (6084890)
W Xiao (6084893)
BS Xu (6084896)
XZ Wen (6084899)
DS Weng (6084902)
X Zhang (6084905)

December 2018

Information of 277 eligible Trials with ClinicalTrials.gov identification numbers in this study. (XL...

Additional file 2: of Revie â: the influence of a life review intervention including a positive, patient-centered approach towards enhancing the personal dignity of patients with advanced cancerâa study protocol for a feasibility study using a mixed method investigation

Maria Da Rocha Rodrigues (3519845)
Sophie Pautex (3519848)
Maya Shaha (3519842)

October 2016

SPIRIT 2013 statement checklist: recommended items to address in a clinical trial protocol and relat...

Additional file 1: of Taking patient and public involvement online: qualitative evaluation of an online forum for palliative care and rehabilitation research

Lisa Brighton (5156327)
Sophie Pask (5156336)
Hamid Benalia (5156330)
Sylvia Bailey (4222492)
Marion Sumerfield (5156342)
Jana Witt (5156339)
Susanne de Wolf-Linder (5156324)
Simon Etkind (5156333)
Fliss Murtagh (5156321)
Jonathan Koffman (465745)
Catherine Evans (466948)

May 2018

S1. COREQ checklist for qualitative studies, S2. Focus group topic guide (PPI members), S3. Focus gr...

Additional file 1: Table S1. of A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trial

Amabel Tan (302589)
Anne Goubier (3541961)
Holbrook Kohrt (3541958)

November 2015

Vaccine categories in trial completed prior to 2013, or with planned completion post 2013. Table S2....

Additional file 1: of Recognizing difficult trade-offs: values and treatment preferences for end-of-life care in a multi-site survey of adult patients in family practices

Michelle Howard (3274704)
Nick Bansback (185069)
Amy Tan (4667998)
Doug Klein (4667992)
Carrie Bernard (4668001)
Doris Barwich (4667995)
Peter Dodek (54684)
Aman Nijjar (4667989)
Daren Heyland (614600)

December 2017

Questionnaire asking patients about engagement in advance care planning. (DOCX 37Â kb

Additional file 2: of How do professionals assess the quality of life of children with advanced cancer receiving palliative care, and what are their recommendations for improvement?

Josianne Avoine-Blondin (5185145)
Véronique Parent (5185142)
Léonor Fasse (4596292)
Clémentine Lopez (5185151)
Nago Humbert (5185148)
Michel Duval (447435)
Serge Sultan (201149)

May 2018

Signs associated with the dimensions of QoL from the perspective of professionals in hematology-onco...

Additional file 2: of Characteristics and impact of the most-cited palliative oncology studies from 1995 to 2016

Corbin Eule (6113687)
Nizar Bhulani (3436592)
Elizabeth Paulk (6113690)
Ramona Rhodes (6113693)
Muhammad Beg (6113696)

January 2019

Table S2. Top 100 most-cited palliative oncology studies in 2006-2016. (XLSX 23 kb

Additional file 1: of A randomized controlled trial of a skills training for oncologists and a communication aid for patients to stimulate shared decision making about palliative systemic treatment (CHOICE): study protocol

I. Henselmans (4744968)
E. Smets (4744965)
J. de Haes (4744974)
M. Dijkgraaf (4744971)
F. de Vos (4744962)
H. van Laarhoven (4744977)

January 2018

Instruments main outcome measures (OPTION12 and 4SDM). Instruments used to assess the main outcome (...

Additional file 1: of Access to clinical trials among oncology patients: results of a cross sectional survey

Mariko Carey (671862)
Allison Boyes (2563240)
Rochelle Smits (4444474)
Jamie Bryant (671861)
Amy Waller (2563246)
Ian Olver (3903175)

September 2017

Clinical Trials Questionnaire. Participation in Clinical Trials: Questionnaire items assessing parti...

Additional file 1: of Patientsâ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey

Sing Moorcraft (3426695)
Cheryl Marriott (3426683)
Clare Peckitt (3426692)
David Cunningham (294575)
Ian Chau (3426698)
Naureen Starling (3426686)
David Watkins (384424)
Sheela Rao (3426689)

January 2016

Questionnaire A. Description: questionnaire given to patients who consented to a clinical trial. (DO...

Additional file 2: of Patientsâ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey

Sing Moorcraft (3426695)
Cheryl Marriott (3426683)
Clare Peckitt (3426692)
David Cunningham (294575)
Ian Chau (3426698)
Naureen Starling (3426686)
David Watkins (384424)
Sheela Rao (3426689)

January 2016

Questionnaire B. Description: questionnaire given to patients who declined a clinical trial. (DOC 15...

Additional file 1: of Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy

Loisa Drozdoff (5784020)
Evelyn Klein (3166416)
Marion Kiechle (268312)
Daniela Paepke (5784023)

November 2018

Questionnaire. This additional file contains the delivered survey for the patients of our chemothera...

Additional file 3: of From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards

Júlia Perera-Bel (4968799)
Barbara Hutter (420459)
Christoph Heining (4968805)
Annalen Bleckmann (318840)
Martina Fröhlich (2186257)
Stefan Fröhling (4968802)
Hanno Glimm (200902)
Benedikt Brors (14082)
Tim Beißbarth (31587)

March 2018

Percentage of patients of the top ten biomarkers at each level of evidence in each tumor type. Level...

Additional file 1: of A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer

Kazuhisa Yamaguchi (3473369)
Hiroya Taniguchi (3473354)
Azusa Komori (3473363)
Yukiya Narita (3473339)
Sohei Nitta (3473345)
Motoo Nomura (3473360)
Shigenori Kadowaki (3473348)
Daisuke Takahari (3473351)
Takashi Ura (3473366)
Masashi Andoh (3473357)
Kei Muro (3473336)
Keita Mori (428401)
Yoshinori Igarashi (3473342)

August 2015

Summary of chemotherapies for metastatic colorectal cancer in the various setting. (PDF 133Â kb

Additional file 1: of Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)

W. Koemans (6670517)
R. Kaaij (6670523)
H. Boot (3665377)
T. Buffart (6670529)
A. Veenhof (6670532)
K. Hartemink (6670535)
C. Grootscholten (6670538)
P. Snaebjornsson (6670541)
V. Retel (6670544)
H. Tinteren (6670547)
S. Vanhoutvin (6670550)
V. Noort (6670553)
A. Houwink (6670556)
C. Hahn (3977039)
A. Huitema (6670559)
M. Lahaye (1559098)
M. Los (4258465)
P. Barselaar (6670562)
O. Imhof (6670565)
A. Aalbers (6670568)
G. Dam (6088175)
B. Etten (6670571)
B. Wijnhoven (6670574)
M. Luyer (6670577)
D. Boerma (6670580)
J. Sandick (6670583)

May 2019

Inclusion and exclusion criteria of the PERISCOPE II trial. List of all in and exclusion criteria. (...

Additional file 1: of The changing landscape of phase II/III metastatic sarcoma clinical trialsâanalysis of ClinicalTrials.gov

Y Que (6084890)
W Xiao (6084893)
BS Xu (6084896)
XZ Wen (6084899)
DS Weng (6084902)
X Zhang (6084905)

December 2018

Information of 277 eligible Trials with ClinicalTrials.gov identification numbers in this study. (XL...

Additional file 2: of Revie â: the influence of a life review intervention including a positive, patient-centered approach towards enhancing the personal dignity of patients with advanced cancerâa study protocol for a feasibility study using a mixed method investigation

Maria Da Rocha Rodrigues (3519845)
Sophie Pautex (3519848)
Maya Shaha (3519842)

October 2016

SPIRIT 2013 statement checklist: recommended items to address in a clinical trial protocol and relat...

Additional file 1: of Taking patient and public involvement online: qualitative evaluation of an online forum for palliative care and rehabilitation research

Lisa Brighton (5156327)
Sophie Pask (5156336)
Hamid Benalia (5156330)
Sylvia Bailey (4222492)
Marion Sumerfield (5156342)
Jana Witt (5156339)
Susanne de Wolf-Linder (5156324)
Simon Etkind (5156333)
Fliss Murtagh (5156321)
Jonathan Koffman (465745)
Catherine Evans (466948)

May 2018

S1. COREQ checklist for qualitative studies, S2. Focus group topic guide (PPI members), S3. Focus gr...

Additional file 1: Table S1. of A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trial

Amabel Tan (302589)
Anne Goubier (3541961)
Holbrook Kohrt (3541958)

November 2015

Vaccine categories in trial completed prior to 2013, or with planned completion post 2013. Table S2....

Additional file 1: of Recognizing difficult trade-offs: values and treatment preferences for end-of-life care in a multi-site survey of adult patients in family practices

Michelle Howard (3274704)
Nick Bansback (185069)
Amy Tan (4667998)
Doug Klein (4667992)
Carrie Bernard (4668001)
Doris Barwich (4667995)
Peter Dodek (54684)
Aman Nijjar (4667989)
Daren Heyland (614600)

December 2017

Questionnaire asking patients about engagement in advance care planning. (DOCX 37Â kb

Additional file 2: of How do professionals assess the quality of life of children with advanced cancer receiving palliative care, and what are their recommendations for improvement?

Josianne Avoine-Blondin (5185145)
Véronique Parent (5185142)
Léonor Fasse (4596292)
Clémentine Lopez (5185151)
Nago Humbert (5185148)
Michel Duval (447435)
Serge Sultan (201149)

May 2018

Signs associated with the dimensions of QoL from the perspective of professionals in hematology-onco...

Additional file 2: of Characteristics and impact of the most-cited palliative oncology studies from 1995 to 2016

Corbin Eule (6113687)
Nizar Bhulani (3436592)
Elizabeth Paulk (6113690)
Ramona Rhodes (6113693)
Muhammad Beg (6113696)

January 2019

Table S2. Top 100 most-cited palliative oncology studies in 2006-2016. (XLSX 23 kb

Additional file 3: of Decision aids for second-line palliative chemotherapy: a randomised phase II multicentre trial

Abstract

Extracted data

Additional file 3: of Decision aids for second-line palliative chemotherapy: a randomised phase II multicentre trial

Abstract

Extracted data

Topics

Related items

Topics

Related items